The Benlysta market is witnessing steady growth over the forecast period, supported by rising lupus diagnosis rates, expanded indications such as lupus nephritis.
Read More
The Benefix market is witnessing steady growth over the forecast period, supported by increasing prophylaxis uptake, improved recombinant manufacturing.
Read More
The BayTet market is witnessing steady growth over the forecast period, supported by growth in emergency care access, improved injury management standards.
Read More
The Bayrho-D market is witnessing steady growth over the forecast period, supported by growth in non invasive prenatal testing, increasing maternal health programs.
Read More
The Bayrab market is witnessing steady growth over the forecast period, supported by increasing stray animal populations, expansion of global vaccination coverage.
Read More
The Bayhep B market is witnessing steady growth over the forecast period, supported by growth in liver transplant procedures, increasing hepatitis screening rates.
Read More
The Baygam market is witnessing steady growth over the forecast period, supported by increasing animal bite incidents, expansion of vaccination programs.
Read More
The Bavencio (Avelumab) market is witnessing steady growth over the forecast period, supported by expansion into new tumor indications, increasing global immunotherapy adoption.
Read More
The BAT (Botulism Antitoxin Heptavalent) market is witnessing steady growth over the forecast period, supported by rising biodefense investments, growth in national stockpile programs.
Read More
The Basaglar market is witnessing steady growth over the forecast period, supported by continued growth in diabetic population, biosimilar substitution policies.
Read More